Imiquimod stimulates innate and cell mediated immunity which controls virus infections and tumors
- 1 May 2002
- journal article
- Published by Wiley in International Journal of Dermatology
- Vol. 41 (s1) , 3-6
- https://doi.org/10.1111/j.1365-4632.2002.00017.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trialJournal of the American Academy of Dermatology, 2001
- Imiquimod 5% cream in the treatment of Bowen's diseaseJournal of the American Academy of Dermatology, 2001
- Imiquimod, a Topical Immune Response Modifier, Induces Migration of Langerhans Cells11The authors have declared a conflict of interest.Journal of Investigative Dermatology, 2000
- Estimates of the Incidence and Prevalence of Sexually Transmitted Diseases in the United StatesSexually Transmitted Diseases, 1999
- Review Article Imiquimod applied topically: a novel immune response modifier and new class of drugInternational Journal of Immunopharmacology, 1999
- Modulation of TH1 and TH2 Cytokine Production with the Immune Response Modifiers, R-848 and ImiquimodCellular Immunology, 1999
- Epidemiology of Genital Human Papillomavirus InfectionThe American Journal of Medicine, 1997
- Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 CellsThe Journal of Experimental Medicine, 1997
- Regulation of the Interleukin (IL)-12R β2 Subunit Expression in Developing T Helper 1 (Th1) and Th2 CellsThe Journal of Experimental Medicine, 1997
- Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigsAntimicrobial Agents and Chemotherapy, 1994